David A. Santos
2020
In 2020, David A. Santos earned a total compensation of $1.2M as Executive Vice President and Chief Commercial Officer at Rigel Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $819,854 |
|---|---|
| Option Awards | $155,625 |
| Salary | $163,726 |
| Other | $51,397 |
| Total | $1,190,602 |
Santos received $819.9K in non-equity incentive plan, accounting for 69% of the total pay in 2020.
Santos also received $155.6K in option awards, $163.7K in salary and $51.4K in other compensation.
Rankings
In 2020, David A. Santos' compensation ranked 7,867th out of 13,090 executives tracked by ExecPay. In other words, Santos earned more than 39.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,867 out of 13,090 | 40th |
Division Manufacturing | 3,331 out of 5,618 | 41st |
Major group Chemicals And Allied Products | 1,350 out of 2,251 | 40th |
Industry group Drugs | 1,172 out of 1,951 | 40th |
Industry Pharmaceutical Preparations | 874 out of 1,456 | 40th |
Source: SEC filing on April 6, 2021.
Santos' colleagues
We found four more compensation records of executives who worked with David A. Santos at Rigel Pharmaceuticals in 2020.